Phase II Trial to Evaluate Trametinib in Patients With Advanced NF1-mutant Non-small Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 07 May 2018
At a glance
- Drugs Trametinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 16 Feb 2018 Status changed from not yet recruiting to recruiting.
- 12 Jan 2018 Planned initiation date changed from 8 Dec 2017 to 1 Jul 2018.